ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1395

Poor Maternal and Fetal Outcome in Indian Women with Systemic Sclerosis: Interview-based Study at a Tertiary Center in India

Rajat Kharbanda1, Naveen R2, Durga P Misra2, Latika Gupta3 and Vikas Agarwal4, 1SGPGIMS, Lucknow, Lucknow, Uttar Pradesh, India, 2Sanjay Gandhi Post graduate institute of medical sciences, Lucknow, Uttar Pradesh, India, 3Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 4Sanjay Gandhi Post Graduate Institute of Medical Sciences, LUCKNOW, India

Meeting: ACR Convergence 2020

Keywords: pregnancy, Systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Poor obstetric outcomes have been described in Systemic sclerosis (SSc) in the developed world. We assessed effect of the disease in Indian women and compared with world literature. 

Methods: Women with SSc ( >18 years, ACR/EULAR 2013 criteria)1 registered at a tertiary care centre from 2010-2016 were contacted over the telephone. Apart from demographics, disease related features, obstetric history and social issues were recorded (Figure 1).

Results: Of 200 women, 94 (47%) could be contacted, 13 (of 94, 13.8%) deaths were recorded, and 75 (79.8%) agreed for an interview (baseline characteristics Table 1). Median age at diagnosis was 31 (22-38) years. Diffuse SSc was more common (56%).

127 conceptions before SSc were compared with 15 after the disease (Figure 2) to yield a higher odd of maternal [OR: 4.9] and foetal [OR: 9.9] complications, and low chances of a live births [OR: 0.23]. Pregnancies after SSc had higher spontaneous abortion, premature rupture of membrane (PROM), prolonged labor, oligohydramnios, maternal infection and intrauterine death (IUD), preterm delivery, low birth weight (LBW) (Table 1)].  Greater (66.7% vs 52%)2 caesarean deliveries were recorded after disease onset. Social issues were reported by 12 (16%).

As compared to SSc in developed countries,2,3,4 we found a similar caesarean (two-third) and preterm deliveries (one-fourth), whereas abortion rate was six times higher (26.6% vs 4%) and LBW was 20%, which was 1.5 times higher compared to IMPRESS cohort.2

Conclusion: SSc incurs high mortality, poor obstetric outcomes, greater maternal and foetal complications, and low birth weight in addition to social issues. The outcomes are worse in a low-middle income country than previously described from the developed world.

Figure 1: Detailed Methods

Figure 2: Maternal and fetal complications in Systemic sclerosis

Table 1: Comparison of Obstetric outcomes before and after onset of Systemic sclerosis


Disclosure: R. Kharbanda, None; N. R, None; D. Misra, None; L. Gupta, None; V. Agarwal, None.

To cite this abstract in AMA style:

Kharbanda R, R N, Misra D, Gupta L, Agarwal V. Poor Maternal and Fetal Outcome in Indian Women with Systemic Sclerosis: Interview-based Study at a Tertiary Center in India [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/poor-maternal-and-fetal-outcome-in-indian-women-with-systemic-sclerosis-interview-based-study-at-a-tertiary-center-in-india/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/poor-maternal-and-fetal-outcome-in-indian-women-with-systemic-sclerosis-interview-based-study-at-a-tertiary-center-in-india/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology